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Fifty patients with hypertrophic cardiomyopathy under-
went invasive study of coronary and myocardial hemo-
dynamics in the basal state and during the stress of
pacing. The 23 patients with basal obstruction (average
left ventricular outflow gradient, 77 ± 33 mm Hg; left
ventricular systolic pressure, 196 ± 33 mm Hg, mean
± 1 SD) had significantly lower coronary resistance (0.85
± 0.18 versus 1.32 ± 0.44 mm Hg-min/ml, p < 0.001)
and higher basal coronary flow (l06 ± 20 versus 80 ±
25 ml/min, p < 0.001) in the anterior left ventricle,
associated with higher regional myocardial oxygen con-
sumption (12.4 ± 3.6 versus 8.9 ± 3.3 ml oxygen/min,
p < 0.001) compared with the 27 patients without ob-
struction (mean left ventricular systolic pressure 134 ±
18 mm Hg, p < 0.001).
Myocardial oxygen consumption and coronary blood
flow were also significantly higher at paced heart rates
of 100 and 130 beats/min (the anginal threshold for 41
of the 50 patients) in patients with obstruction compared
with those without. In patients with obstruction, trans-
mural coronary flow reserve was exhausted at a heart
rate of 130beats/min; higher heart rates resulted in more
The most characteristic feature of hypertrophic cardio-
myopathy is hypertrophy of the left ventricle without ob-
vious physiologic explanation (I). In many patients with
this disease, an intraventricular pressure gradient can be
demonstrated, localized to the site of apposition of the mitral
valve with the septum (2-5). However, controversy exists
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severe metabolic evidence of ischemia with all patients
experiencing chest pain, associated with an actual in-
crease in coronary resistance. Patients without obstruc-
tion also demonstrated evidence of ischemia at heart
rates of 130 and 150 beats/min, with 25 of 27 patients
experiencing chest pain. In this group, myocardial isch-
emia occurred at significantly lower coronary flow, higher
coronary resistance and lower myocardial oxygen con-
sumption, suggesting more severely impaired flow de-
livery in this group compared with those with obstruc-
tion. Abnormalities in myocardial oxygen extraction and
marked elevation in filling pressures during stress were
noted in both groups.
Thus, obstruction to left ventricular outflow is as-
sociated with high left ventricular systolic pressure and
oxygen consumption and therefore has important patho-
genetic importance to the precipitation of ischemia in
patients with hypertrophic cardiomyopathy. Patients
without obstruction may have greater impairment in
coronary flow delivery during stress.
(J Am Call Cardiol 1987;10:53-62)
as to whether this phenomenon represents true mechanical
obstruction to left ventricular systolic ejection (5-10), In
symptomatic patients with fixed mechanical obstruction to
left ventricular outflow, such as aortic stenosis, a high left
ventricular systolic pressure results in elevated absolute basal
coronary flow and myocardial oxygen consumption (11-13),
and limited coronary flow reserve has been demonstrated
intraoperatively (14). The present study was performed to
examine whether patients with and patients without basal
obstruction to left ventricular outflow differ with regard to
coronary and myocardial hemodynamics and therefore ver-
ify whether the subaortic gradient and elevated intraven-
tricular pressures in hypertrophic cardiomyopathy are of
pathophysiologic consequence,
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Methods
Patient selection. We studied 50 patients with an echo-
cardiographic diagnosis of hypertrophic cardiomyopathy.
All patients had a hypertrophied, nondilated left ventricle
in the absence of another cardiac or systemic disease capable
of causing myocardial hypertrophy (I) and had angiograph-
ically normal epicardial coronary arteries. Thirty-six pa-
tients were men and 14 were women, ranging in age from
22 to 60 years (mean 43). No patient had previously under-
gone cardiac surgery. All patients were severely sympto-
matic (New York Heart Association functional class III to
IV) and 48 of the 50 described chest pain as a major symp-
tom. This study represents a consecutive series of patients
with hypertrophic cardiomyopathy who underwent the cath-
eterization study protocol. Patients were considered to have
basal obstruction to left ventricular outflow if their basal
pressure gradient was ;::::30 mm Hg. Data from 18 of these
patients have been reported previously (15). Informed con-
sent for this study was obtained from all patients.
Echocardiographic studies. A combined M-mode and
two-dimensional echocardiographic examination was per-
formed in each of the 50 study patients. M-mode echocar-
diograms were performed with an Irex System II ultrasound
unit with either a 2.25 or 3.5 MHz transducer. Two-di-
mensional echocardiograms were performed with either a
Varian V-3400 or ATL (Advanced Technology Laboratory,
Inc.) MK-500 ultrasound system with 2.25 or 3.5 MHz
transducers, respectively. In 42 of the 50 study patients in
whom two-dimensional echocardiograms were of adequate
quality, assessment of the magnitude of left ventricular hy-
pertrophy was made primarily from the parasternal short-
axis cross-sectional plane, as previously described (16). The
ventricle was divided into four regions that identified the
anterior and posterior ventricular septum and the lateral and
posterior left ventricular free wall. Wall thickness of each
region was measured directly from the television monitor
with calipers, using a calibration scale produced by the
instrument. A wall thickness index was calculated by adding
the measurements of maximal wall thickness obtained in
each of the four segments into which the ventricle had been
divided. The calculated score was considered a quantitative
expression of the overall magnitude of left ventricular hy-
pertrophy. All measurements were performed by one in-
vestigator without knowledge of the catheterization study
results.
Cardiac catheterization: coronary flow and myo-
cardial metabolism. All medications, including f3-adre-
nergic blockers and calcium channel blockers, were ter-
minated at least 48 hours or 5 drug half-lives before cardiac
catheterization. After sedation with diazepam, 10mg orally,
patients were taken to the catheterization laboratory, usually
at 8:00 AM in the fasting state and without any other pre-
medication. A Baim thermodilution flow catheter (17) (Ele-
cath Corp.) was introduced into the right atrium through the
right internal jugular vein. The great cardiac vein, which is
the recipient of blood from the left anterior descending artery
system, was cannulated through the coronary sinus. Hand
injections of contrast dye were recorded on cine film, dem-
onstrating the catheter tip at the junction of the anterior
interventricular vein and great cardiac vein without adjacent
marginal veins in all cases. The catheter position was kept
constant throughout the study by frequent inspection of the
relation of the electrodes on the catheter to bony landmarks
by fluoroscopy. The thermodilution technique for deter-
mining great cardiac vein flow has been described previously
(18,19). All temperature determinations were fed directly
into an IBM PClXT computer, averaging 20 seconds of
infusate-blood mixture for each flow determination, with
on-line calculation of great cardiac vein flow using a stan-
dard formula (17).
This method of coronary flow measurement was chosen
for two reasons: First, in our experience, the catheter ad-
vanced into the great cardiac vein is stable in position with
minimal or no movement even during pacing, and repro-
ducible flow measurments may be achieved at rest and dur-
ing pacing. Second, measurements of venous flow from the
anterior left ventricular wall may allow estimation of coro-
nary flow and myocardial metabolism in that portion of the
ventricle most abnormal in the majority of patients with
hypertrophic cardiomyopathy, that is, the anterior septum
and free wall (16). Coronary sinus flow measurements were
not recorded because of concern for right atrial reflux during
pacing (20). Coronary resistance was calculated as the mean
blood pressure divided by the great cardiac vein flow.
A 20 gauge catheter was placed in the left brachial artery
for arterial pressure measurements. An 8F end-hole pigtail
catheter (in 31 patients, a transducer-tipped catheter, Millar
Instruments) was advanced into the left ventricle. Cardiac
output and pulmonary artery wedge pressures were mea-
sured with a thermodilution catheter in the pulmonary artery.
Cardiac index was calculated as cardiac output divided by
the body surface area. Systemic vascular resistance index
was calculated as mean systemic blood pressure divided by
the cardiac index. Arterial and left ventricular pressures and
electrocardiographic (ECG) monitor leads I, aVF and V3
or V5 were recorded with each flow measurement in the
great cardiac vein. Lactate samples were obtained from the
great cardiac vein and brachial artery and immediately trans-
ferred to tubes containing sodium fluoride and potassium
oxalate for inhibition of glycolysis, with immediate cen-
trifugation at 4°C at 5,000 rpm for 5 minutes. The super-
natant was then processed for lactate content on a DuPont
automatic clinical analyzer by a modification of the tech-
nique of Marbach and Weil (21). Lactate consumption was
calculated as the difference between the arterial and great
cardiac vein lactate concentrations multiplied by the great
cardiac vein flow. Oxygen content was determined with a
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Lex-Oj-Con oxygen analyzer (Lexington Instruments) at
rest and during pacing. Myocardial oxygen consumption in
the anterior circulation was calculated as the difference be-
tween the arterial and great cardiac vein oxygen content
multiplied by the great cardiac vein flow.
Diagnostic catheterization: ventricular outflow ob-
struction. Before the pacing coronary flow study, all pa-
tients underwent diagnostic right and left heart catheteriza-
tion. Obstruction to left ventricular outflow was defined as
the presence of an intraventricular gradient of ::::30 mm Hg
localized to the left ventricular outflow tract during pullback
of an end-hole catheter. Care was taken to exclude artifactual
distortion of the left ventricular pressure by catheter en-
trapment as described by Wigle et al. (22). Although ma-
neuvers to provoke an outflow gradient, including the Val-
salva maneuver, amyl nitrite inhalation and isoproterenol
infusion, were used to assess the presence and severity of
a left ventricular outflow gradient in many patients, only
the basal left ventricular outflow gradient was used to dis-
tinguish patients with from those without obstruction to left
ventricular outflow in this study. In 47 patients, coronary
arteriography, using multiple angulated views, was per-
formed after completion of hemodynamic studies. In the
remaining three patients, coronary arteriography was per-
formed before referral to the Cardiology Branch, National
Heart, Lung, and Blood Institute. Left ventriculography was
performed in 45 study patients. Left ventricular ejection
fraction was estimated from the left ventriculogram in the
45° right anterior oblique projection using the area-length
method of Sandler and Dodge (23).
Pacing coronary flow study. The study protocol was
initiated at least 20 minutes after the use of angiographic
contrast material to eliminate any effects of the dye on
coronary flow and myocardial metabolism (24). Great car-
diac vein flow, lactate and oxygen content were determined
at rest as were measurements of cardiac output, mean pul-
monary artery wedge pressure and left ventricular peak sys-
tolic and end-diastolic pressures. Pacing through the coro-
nary sinus thermodilution catheter was initiated at a heart
rate of 100 beats/min in the 45 patients whose basal heart
rates were < 100 beats/min, and increased by increments of
10 beats/min at I to 2 minute intervals up to a heart rate of
150 beats/min in 48 patients. Atropine, 0.5 to 1.0 mg, was
given intravenously to seven patients to facilitate rapid atrial
pacing. In two patients, pacing was terminated at 130
beats/min because of the severity of chest pain. Arterial and
left ventricular pressures and great cardiac vein flow were
measured at each heart rate. Left ventricular end-diastolic
pressure was measured at heart rates of 100, 130 and 150
beats/min. At heart rates of 100 and 130 beats/min, the left
ventricular end-diastolic pressure was measured after sudden
termination of pacing in 31 patients and during pacing in
the rest, with an average of pressures over a 10 second
interval, excluding the first four postpacing beats. After
pacing for 2 minutes at a heart rate of 150 beats/min, the
left ventricular end-diastolic pressure was measured im-
mediately after termination of pacing in 48 patients using
the same criteria. Cardiac output determinations were made
in triplicate at heart rates of 130 and 150 beats/min and
averaged. Blood specimens from the great cardiac vein and
brachial artery were obtained at heart rates of 130 and 150
beats/min for oxygen and lactate content. ECG analysis was
performed only in the immediate postpacing ECG, which
was compared with the record obtained before pacing.
Statistical analyses. Data were analyzed by the two-
tailed Student's t test for paired and unpaired data when
appropriate, with the probability (p) value <0.05 considered
statistically significant. Regression analyses were performed
when indicated. All group data are reported as mean ± 1
SD.
Results
Echocardiographic evaluation (Table 1). In each of
the 50 study patients, hypertrophy of the anterior ventricular
septum (thickness > IS mm) was identified by both M-mode
and two-dimensional echocardiography. In 42 patients (21
with obstruction, 21 without obstruction), two-dimensional
echocardiographic studies were of satisfactory quality to
permit estimation of the magnitude and extent of left ven-
tricular hypertrophy. The maximal thickness of the anterior
septum (the region of the left ventricle drained in part by
the great cardiac vein) was 20 ± 3 mm in patients with
obstruction and 20 ± 6 mm in those without obstruction.
Table 1. Quantitation of Left Ventricular Hypertrophy
HCM-N HCM-O p Value
No. of patients
Male/female
Maximal thickness of LV (mm)
Thickness of anterior septum (mm)
Index of overall LV hypertrophy (mm)
21
17/4
22 ± 5
20 ± 6
61 ± 15
21
14/7
19 ± 5
20 ± 3
60 ± 14
NS
NS
NS
NS
NS
HCM-N and HCM-O = nonobstructive and obstructive hypertrophic cardiomyopathy, respectively; LV =
left ventricle.
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There was no significant difference in the distribution or
severity of hypertrophy between patients with and without
basal left ventricular outflow obstruction.
Angiographic evaluation. By study inclusion criteria,
all patients had entirely normal epicardial coronary arteries.
Basal coronary flow in the left coronary artery appeared in
most patients to be higher than normal as evidenced by rapid
transit of contrast medium injected into the coronary ostia .
There was often a complete cessation of dye movement in
systole, with rapid transit in diastole . Systolic compression
of septal perforating vessels was noted in 19 (86%) of 22
patients with obstruction and 16 (64%) of2S patients without
obstruction whose coronary arteriograms were available for
review. Systolic compression of epicardial vessels was noted
in one patient with obstruction and two patients without
obstruction. Left ventriculography generally demonstrated
an elongated, hyperdynamic ventricle with massive hyper-
trophy of papillary muscles , giving a "ballerina slipper"
appearance. Evidence of mitral regurgitation was noted in
19 (86%) of 22 patients with obstruction and 8 (35%) of
23 patients without obstruction whose ventriculograms were
available for review. The angiographic ejection fraction was
increased in both groups: 81 ± 8% in the nonobstructive
group, 81 ± 10% in the obstructive group.
Basal coronary and myocardial hemodynamics (Table
2, Fig. 1 and 2). In the basal state, 23 patients had an
intraventricular gradient of 2:30 mm Hg (77 ± 33) localized
to the left ventricular outflow tract; 27 patients had either a
minimal or no basal gradient (3 ± 7 mm Hg). There was
a significant relation between the basal left ventricular sys-
tolic pressure and great cardiac vein flow (r = 0.51, P <
0.001) (Fig . IA) and coronary resistance (r = 0.41 , P <
0.01) (Fig. 28), although wide variation was noted. Whereas
the left ventricular systolic pressure was higher in patients
with obstruction, the mean systemic pressure was signifi-
cantly lower in patients with than in those without obstruc-
tion (88 ± 12 versus 96 ± 13 mm Hg, p < 0.05) . Ad-
ditionally, the basal heart rate was higher in patients with
obstruction (83 ± 13 versus 75 ± 11 beats/min, p < 0.005).
The basal great cardiac vein flow was significantly higher
(106 ± 20 versus 80 ± 25 mllmin, p < 0.(01) and coronary
resistance lower (0.85 ± 0.18 versus 1.32 ± 0.44 mm
Hg-min/rnl, p < 0.001) in the patients with obstruction (Fig.
2) and was associated with greater myocardial oxygen con-
sumption in the anterior left ventricular septum and free
wall than that in patients without obstruction (12.4 ± 3.6
versus 8.9 ± 3.3 ml oxygen/min, p < 0.01). Myocardial
oxygen consumption, even when normalized for heart rate,
was still significantly higher in the group with obstruction
(0.15 ± 0.05 versus 0.12 ± 0.04 ml oxygen/min, p <
0.025). Left ventricular filling pressures, as estimated by
the left ventricular end-diastolic and mean pulmonary artery
wedge pressures, were similar for the two groups.
Coronary and myocardial hemodynamics during pac-
ing (Table 2, Fig. 2 to 4). In the 45 patients whose basal
heart rate was < 100 beats/min, atrial pacing was initiated
at 100 beats/min. Two patients (one with and one without
obstruction ) experienced chest pain at this heart rate. The
left ventricular systolic pressure was significantly higher
(181 ± 30 versus 136 ± 21 mm Hg, p < 0.001) and mean
systemic blood pressure significantly lower (91 ± 16 versus
100 ± 14 mm Hg, p < 0.05) in the patients with than in
those without obstruction to left ventricular outflow . Coro-
nary resistance decreased in both groups in response to the
stress of pacing, but was significantly lower (0.76 ± 0.27
versus 1.09 ± 0.44 mm Hg-min/rnl, p < 0.005) and the
great cardiac vein flow higher (132 ± 46 versus 104 ± 38
milmin, p < 0.05) in patients with obstruction. The left
ventricular end-diastolic pressure was minimally increased
from basal measurements at this heart rate .
Pacing at a heart rate of 130 beats/min (performed in
each of the 50 patients) resulted in anginal chest pain in all
but 9 patients, regardless of the presence or absence of
outflow obstruction. 111 response to this stress , mean sys-
temic pressure rose in both groups, and was no longer sig-
nificantly different. Additionally, the left ventricular systolic
pressure fell in the group with basal outflow obstruction,
resulting in a reduction of outflow gradient to 49 ± 30 mm
Hg. Still, the left ventricular systolic pressure was signifi-
cantly higher in the group with obstruction (173 ± 28 versus
132 ± 25 mm Hg, p < 0.001), as was coronary flow (155
± 40 versus 125 ± 42 ml/rnin, p < 0.025) and myocardial
oxygen consumption (18.1 ± 6.8 versus 13.0 ± 4.2 ml
oxygen/min, p < 0.01) . Coronary resistance was signifi-
cantly lower in the group with obstruction (0.67 ± 0.17
versus 0.95 ± 0.42 mm Hg-min/ml, p < 0.005). Metabolic
evidence for ischemia was apparent in both groups at this
heart rille, along with a decline in lactate consumption,
reflecting decreased lactate extraction compared with base-
line measurements , and actual lactate production in four
patients (Fig. 3). Further evidence for ischemia was the
significant elevation in left ventricular end-diastolic pressure
in both groups compared with the basal state . Despite the
onset of ischemia in the majority of patients in both groups,
there was no overall increase in oxygen extraction in either
group (Fig. 4).
At a heart rate of 150 beats/min in 48 patients, all but
2 patients (both in the group without basal obstruction)
experienced chest pain, often to a severe degree . The mean
systemic pressure further increased in both groups. As the
cardiac index fell in both groups compared with basal mea-
surements, the increase in mean systemic pressure in both
groups was related to an increase in systemic vascular re-
sistance . Although the left ventricular systolic pressure and
outflow gradient fell further in the group with basal obstruc-
tion, the left ventricular systolic pressure was still signifi-
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Table 2. Hemody namic Data During Pacing Study in 50 Patients With Hypertrophic Cardiomyopathy
(A - V) O2 = arte ria l - great ca rd iac vein oxygen diffe rence ; GCV = grea t ca rdiac vein ; LV EDP = left ve ntr icu lar end-diasto lic pressure ; MV02 = myocard ial
oxygen co nsump tion in the anterior c irculation I(A - V) O 2 X GCV flow]; O2 = oxygen; PCW = mean pu lmonary artery wedge pressure ; oth er abbrev iations as in
Tabl e 1.
Basal Pacin g: 100 beats/mi n Paci ng : 130 beats/min
HCM -N HCM -O P Value HCM-N HCM -O P Value HCM -N HCM -O P Value
75 :t: 11 83 :t: 13 < 0.005 100 100 130 130
96 :t: 13 88 :t: 12 < 0.05 100 :t: 14 9 1 :t: 16 < 0 .05 103 :t: 16 98 :t: 13
134 ::!: 18 196 ::!: 33 < 0.00 1 136 ± 2 1 181 :t: 30 < 0 .00 1 132 :t: 25 173 :t: 28 < 0 .00 1
3 ::!: 7 77 :t: 33 < 0.00 1 3 ± 7 64 :t: 27 < 0 .00 1 1 :t: 4 49 :t: 30 < 0 .00 1
3. 1 :t: 0 .6 3.0 :t: 0.4 3 .0 :t: 0 .7 3 .0 ± 0.4
32 .7 ± 8. 1 30 .1 :t: 6 .7 35 ,9 :t: 9 .8 32 ,6 :t: 7.0
17.9 ± 2.0 18. 1 :t 3.0
6. 7 = 1.5 6.5 = 1.7
11.2 ± 1.6 11.6 = 1.9
8 .9 :t: 3.3 12.4 ± 3.6 < 0 .00 1
25.4 ± 20.3 30 .0 :t: 22.3
17 :t: 7 16 ± 6 18 :t: 7 18 ± 7
14 = 7 12 = 4
oo f 27 oof 23 I of 26 I of 19
7.0 ± 1.1 6 .8 = 1.7 7.2 :t: 1.5 7.2 ± 1.6
10 .9 :t: 1.4 11.5 = 2.0 11.3 ± 2.0 11.4 :t 2.0
13 .0 =4 .2 18. 1 = 6 .8 < 0. 0 1 15. 2 :t: 5 . 1 16 .1 ± 5 .4
20 .8 :t: 29 .0 17 .0 = 23.4 3.0 ± 51.8 - 20 .8 = 35.3
22 :t: 10 2 1 ± 8 27 :t: 10 28 ± 7
18 ± 9 19 :t: 4 22 ± 10 2 1 :t: 7
22 o f 27 19 of 23 24 of 26 22 o f 22
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18 .5 ± 3.2
140 ± 32
0 .76 :t: 0 . 15
Pacing : 150 beats/min
HCM -N HCM -O P Valu e
150 150
107 = 2 1 103 ± 14
133 = 25 157 :t: 25 < 0 .005
::!: 4 32 :t: 25 < 0.00 1
2.7 ± 0 .8 2.7 :t: 0 .5
42.7 ± 13.8 39 .6 ± 10.1
18.4 ± 2.2
130 ± 4 1
0 .90 :t: 0 .31
< 0. 025
< 0 .005
18 .1 ± 2.8
155 ± 40
0 .67 :t: 0. 17
17.8 ± 2.2
125 = 42
0 .95 ± 0.42
< 0 .05
< 0 .005
132 :t: 46
0 .76 :t: 0 .27
104 ± 38
1.09 :t: 0.44
< 0.00 1
< 0.00 1
106 :t: 20
0 .85 :t 0 .18
80 ± 25
1.32 :t 0.44
Heart rate (bea ts/min)
Mean sys temic pressu re
(mm Hg)
LV systo lic pressure
(mrn Hg)
LV o utflow gradient
(mm Hg)
Cardiac index
(liters/min per m2)
Systemic vascul ar
resistance index
[(mm Hg-rnin -rrr ' j/
liter]
GC V flow (rnl/rnin )
Coron ary resistance
(mm Hg-rnin/ml j
Arte ria l O2
(ml O2/100 ml)
GC V O2 (ml 0 21100 ml)
(A - V) O2 (m l O2/ 100
ml)
MV02 (ml 0 2/min)
Lactate con sumption
(mM 'mllm in)
LVEDP (m m Hg)
PCW (rnrn Hg)
Pat ient s with chest
pai n/No . of pat ient s
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Figure 2. Relation of (A) great cardiac vein (GCY) flow and (B)
coronary resistance in the basal state to left ventricular systolic
pressure in obstructive and nonobstructive hypertrophic cardio-
myopathy (HeM).
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was no overall change in oxygen extraction in either group:
10of 22 patients with basal obstruction and IS of 26 patients
without basal obstruction actually extracted less oxygen than
during the basal state (Fig. 4).
Electrocardiographic changes during study. Despite
precipitation of ischemia that was often severe symptomat-
ically and metabolically, only seven patients (three with and
four without basal obstruction) demonstrated discernible ST
segments shifts (depression in all seven cases) in one or
more of the three monitored leads (I, aYF or Y3 or Ys)
recorded immediately after cessation of pacing. There was
Figure 3. Lactateconsumptionin the basal state and during pacing
at rates of 130 and ISO beats/min in patients with hypertrophic
cardiomyopathy (HCM) with and without obstruction to left ven-
tricular outflow. Lactate consumption <0 indicates production of
lactate by the myocardium.
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Figure 1. A, Left ventricular (LY) systolic pressure; B, myo-
cardial oxygen consumption in the anterior coronary circulation;
C, great cardiac vein (GCY) flow; and D, coronary resistance in
the anterior circulation for patients with hypertrophic cardio-
myopathy. With (open circles) and without (closed circles) ob-
struction to left ventricular outflow. Mean values with I SD are
plotted in the basal state and during pacing. *p < 0.05, **p <
0.025, ***p < 0.01, +p < 0.005, + +p < 0.001 versus patients
without obstruction to left ventricular outflow.
cantly higher in that group compared with the group without
basal obstruction (157 ± 25 versus 133 ± 25 mm Hg, p
< 0.005). Coronary flow and resistance changed little in
the group without obstruction, but coronary flow actually
fell and resistance rose in the group with basal obstruction
at a heart rate of 150 beats/min compared with a heart rate
of 130 beats/min (0.67 ± 0.17 to 0.76 ± 0.15 mm
Hg-rnin/ml, p < 0.01). At a heart rate of 150 beats/min,
left ventricular filling pressures increased markedly in both
groups, and there was clear metabolic evidence of myo-
cardial ischemia: 14 of 22 patients with basal obstruction
and II of 26 patients without basal obstruction produced
lactate (Fig. 3). Despite evidence of severe ischemia, there
:; 100
e Z
~ ~
~ ~ 50
! iz
~ 0
III U 0:::I
0
CD
~ Z2
-50~ ~w
!;( ::J0
t- ou IE -100~
JACC Vol. 10, No.1
July 1987:53-62
CANNON ET AL.
CORONARY FLOW IN HYPERTROPHIC CARDIOMYOPATHY
59
extent of the anterior coronary circulation drained by the
great cardiac vein or abnormalities of the intramural coro-
nary circulation.
Hemodynamic and metabolic responses to cardiac
pacing. We also extended the results of our prior study by
comparing the hemodynamic and metabolic responses of
the left ventricle with the stress of cardiac pacing in patients
with and without basal obstruction. In response to the stress
of pacing at heart rates of 100 and 130 beats/min, coronary
resistance fell in both groups, but to a significantly lower
level in patients with obstruction. At a heart rate of 130
beats/min, coronary resistance was lower and coronary flow
and myocardial oxygen consumption were significantly higher
in the patients with obstruction. The lower coronary resist-
ance and higher coronary flow and myocardial oxygen con-
sumption probably reflect the same physiologic significance
of a higher left ventricular systolic pressure in this group,
as was observed at rest. The heart rate of 130 beats/min
represented the anginal threshold for most patients; at this
rate lactate consumption decreased and left ventricular fill-
ing pressures increased to comparable levels in both groups.
Left ventricular systolic pressure and outflow gradient de-
creased in patients with significant basal obstruction, prob-
ably because of ischemia-induced decrease in contractility
and reduction in ejection velocity, which in turn caused less
systolic anterior motion of mitral valve leaflets. Alterna-
tively, the increase in afterload during stress, probably me-
diated by pain-related increases in systemic vascular re-
sistance, might have distended the left ventricular outflow
tract, thus lessening outflow obstruction.
With further increase in stress to a heart rate of J50
beats/min, all but two patients (both without basal obstruc-
tion) experienced chest pain. In patients with basal obstruc-
tion, the increase in stress at this heart rate was associated
with an actual increase in transmural coronary resistance,
demonstrating that maximal functional flow reserve had been
exhausted in most patients at a heart rate of 130 beats/min.
The increase in resistance may have reflected the compres-
sive effects of elevated filling pressures on the maximally
vasodilated coronary bed in patients with obstruction. In
this regard, Domenech (26) showed detrimental effects of
elevation in preload on coronary flow in the pharmacolog-
ically vasodilated coronary bed, but not the coronary bed
that still had the capacity to autoregulate. Alternatively,
more severe ischemia in this group might have depressed
contractility. thereby reducing myocardial oxygen and flow
requirements and causing, by autoregulatory mechanisms,
an increase in coronary resistance (27). In contrast, coronary
resistance fell slightly in the group without basal obstruction
when heart rate was increased from 130 to 150 beats/min.
Limited coronary flow reserve in patients with hy-
pertrophic cardiomyopathy. Patients with obstruction de-
veloped a higher absolute coronary flow than did those with-
out obstruction. It is possible that this finding was caused
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no attempt to evaluate ST segment shifts during pacing
because of artifact in ST segments produced by pacing.
Figure 4. Arterial minusgreatcardiacvein(GCY)oxygencontent
in the basal state and during pacing in patients with and without
obstruction to left ventricular outflow. HCM = hypertrophic car-
diomyopathy.
Discussion
Coronary flow in hypertrophic cardiomyopathy. We
have previously shown (15) that in the portion of the left
ventricle drained by the great cardiac vein, that is, the an-
terior septum and free wall, patients with hypertrophic car-
diomyopathy have higher absolute rest coronary flow in the
basal state than do patients without structural heart disease.
This finding is presumably related to higher basal myo-
cardial oxygen requirements owing in part to the increased
muscle mass present in patients with hypertrophic cardio-
myopathy. Further, within the group of patients with hy-
pertrophic cardiomyopathy, those with a significant basal
outflow pressure gradient had higher basal flow than did
those without obstruction. In the present larger series of
patients with hypertrophic cardiomyopathy, the significant
relation between coronary resistance and left ventricular
systolic pressure (Fig. 2) indicates that the greater coronary
vasodilation present in patients with obstruction occurred,
at least in part, to satisfy higher myocardial oxygen re-
quirements due to a higher left ventricular systolic pressure
analogous to findings in patients with aortic stenosis (\ 1-13).
Compatible with this concept are the results of our prelim-
inary studies, which show that surgical relief of outflow
obstruction and reduction of left ventricular systolic pressure
are accompanied by a reduction in basal and stress-related
coronary flow and associated with a reduction in metabolic
indexes of ischemia during pacing and improvement in an-
ginal threshold (25). Although the magnitude of basal coro-
nary flow and resistance was related to the left ventricular
systolic pressure in our patients, great individual variation
existed (Fig. 2). This could be explained by differences in
absolute muscle mass in the anterior left ventricular wall,
NON-OBSTRUCTIVE HCM
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cardial coronary artery limitation to coronary flow (42) and
in patients with ischemia due to coronary artery disease (43).
In fact, in many patients in both groups, less oxygen was
extracted during stress compared with the basal state. We
could not demonstrate a relation between myocardial oxygen
extraction and the presence and severity of obstruction, se-
verity of ischemia by lactate production, absolute flow re-
sponse to stress or elevation of left ventricular filling pres-
sures. Thus, the mechanisms responsible for this finding
cannot be determined from the present study, but one pos-
sibility might be arteriovenous shunting within the myo-
Figure 5. Proposed mechanisms of myocardial ischemia in hy-
pertrophic cardiomyopathy (large arrows indicate mechanisms of
greater importance than those indicated by small arrows). Top
panel, Patients with significant basal left ventricular (LV) outflow
obstruction have high basal flow requirements primarily because
of high left ventricular systolic pressure and wall stress. Flow
requirements increase further with stress, rapidly exhausting peak
flow capacity, which in absolute terms may be relatively normal.
Abnormal oxygen extraction capacity may also contribute to or
aggravate ischemia. Elevated filling pressures resulting from isch-
emia have a deleterious compressive effect on the maximally va-
sodilated transmural coronary bed resulting in increased coronary
resistance and a decrease in flow. Lower panel, Patients with little
or no obstruction and lower left ventricular systolic pressure have
lower basal flow requirements (although higher than that of patients
without structural heart disease [15]). During stress, flow reserve
may be compromised by greater impairment in the capacity for
augmenting coronary flow delivery, resulting in ischemia at lower
coronary flow and myocardial oxygen consumption than in patients
with obstruction. Abnormal oxygen extraction capacity may con-
tribute to or aggravate ischemia. Elevation of filling pressures
related to ischemia appears to have a less deleterious effect on
coronary flow than that in patients with obstruction.
by the greater muscle mass present in patients with obstruc-
tion, although there were no group differences in the ech-
ocardiographically estimated extent or severity of hypertro-
phy (Table 1). Another explanation might be that patients
with obstruction have greater capillary density and thus greater
absolute coronary flow capacity than do patients without
obstruction, although higher flows during stress in this group
did not prevent ischemia. Indeed, the peak flows achieved
by many patients with obstruction were similar to those
achieved after dipyridamole infusion in patients with a nor-
mal left ventricle using the same method of coronary flow
measurement (28).
Thus, it seems that the greater peak coronary flow of
patients with obstruction compared with that of patients
without obstruction is due to a greater impairment in the
capacity for augmenting coronary flow delivery of the latter
group rather than an augmented capacity of the former.
However, although patients with obstruction had lower
coronary resistance and higher coronary flow at a heart rate
of 130 beats/min, the variation was large. Thus, many pa-
tients with obstruction appear to have impairment in coro-
nary flow delivery as well. Possible explanations for im-
paired coronary flow delivery in the patients with obstruction
are I) greater dependence of myocardial perfusion on di-
astole because of systolic vascular compression with pro-
longed systolic ejection time (29-31), and 2) lower coronary
perfusion pressure secondary to the subcoronary obstruction
(Table 2). Additional possible explanations for impaired
coronary flow for either the patients with or those without
obstruction are I) abnormalities in diastolic relaxation, which
might impair early filling of the coronary reservoir (32-36),
2) high left ventricular filling pressures in response to isch-
emia with resulting compression of subendocardial coronary
microcirculation (15),3) reduction in normal cross-sectional
area of the coronary microcirculation due to replacement by
abnormal myocellular architecture or fibrosis (37,38), 4)
small vessel disease with diminished luminal area of intra-
mural coronary arteries (39-41), and 5) systolic compres-
sion of septal perforating coronary arteries (which occurred
slightly but not significantly more frequently in patients with
basal obstruction). Which of these considerations were most
important in limiting appropriate coronary flow delivery
during stress cannot be determined from our study.
Oxygen extraction by ischemic myocardium. There
was evidence of severe myocardial ischemia in both groups
in response to high paced heart rates. Although more patients
with basal obstruction produced lactate across the coronary
bed, and the group response to pacing stress was lactate
production (Fig. 3), the mean value of lactate consumption
of patients with and without obstruction did not differ sig-
nificantly. As noted previously (15), there was no augmen-
tation of oxygen extraction from the coronary circulation in
either group, despite metabolic evidence of severe ischemia.
This is in contrast to the response seen in dogs with epi-
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cardium in the presence of high subendocardial compressive
forces.
We have already outlined the major mechanisms we be-
lieve to be potentially responsible for precipitating isch-
emia. However, an additional contributing factor may be
the high ventricular pressure occurring in a ventricle with
obstruction to left ventricular outflow, in which there is
asymmetric distribution and magnitude of hypertrophy un-
like the concentric, uniform hypertrophy present in valvular
aortic stenosis. Thus, transmural wall stress may vary mark-
edly within various regions of the same ventricle, that is,
lowest in the most hypertrophied region and highest in re-
gions of normal wall thickness. These latter regions might
be particularly susceptible to the development of stress-
induced ischemia.
Limitations of study. We have previously discussed
(15) the advantages and disadvantages of estimating coro-
nary flow by the thermodilution method. Ideally, measure-
ment of coronary flow and calculation of resistance per unit
mass would allow greater in sight as to mechanisms re-
sponsible for the limited flow reserve in hypertrophic car-
diomyopathy. Unfortunately, there characteristicallyis marked
heterogeneity in the distribution and amount of hypertrophy
in a given patient and from patient to patient in this disease.
This means that the mass of left ventricle supplied by a
coronary artery (for contrast densitometric or Doppler de-
terminations of flow velocity) or drained by the great cardiac
vein (for thermodilution measurements) in a given patient
cannot be defined, thereby making it impossible to nor-
malize flow for left ventricular mass. Inert gas washout
techniques, which do measure flow per unit mass, require
too long a sampling period (up to 20 minutes) during stress
to be practical and safe. Although no attempt was made to
normalize flow to mass in our study, we do not believe the
differences we observed between the patients with and those
without obstruction could be explained by difference in mass.
The reason for this is that there was no group difference in
the severity of hypertrophy between patients with and pa-
tients without obstruction to left ventricular outflow (Table
l). Further, it seems unlikely that the great cardiac vein
anatomy would differ between the two groups, and therefore
unlikely that different drainage patterns exist. In further
support of the assumption that the higher great cardiac vein
flow in patients with obstruction reflects a true increase in
myocardial oxygen demand, and not anatomic differences
in coronary venous drainage, is the observation (25) that
operative relief of outflow obstruction reduces basal and
stress-induced flow, lessens the severity of ischemia in re-
sponse to stress and lowers anginal threshold.
Despite this limitation. we believe that the thermodilution
estimate of coronary flow in this study provides insight as
to the mechanisms responsible for the limitation in flow
reserve in patients with hypertrophic cardiomyopathy (Fig.
5). For example, in most patients with obstruction, we were
able to demonstrate that limited flow reserve is related pri-
marily to elevated basal flow and stress requirements, rather
than to an impaired peak flow capacity, which is equal to
values observed by us in patients with a normal left ventricle
and coronary arteries after dipyridamole administration (28).
In contrast, limited flow reserve in patients without obstruc-
tion does appear to be due to an impairment in peak flow
capacity in most patients.
Another limitation in this study is the calculation ofcoro-
nary resistance. derived by mean arterial pressure divided
by great cardiac vein flow. This ignores the contribution of
elevated left ventricular filling pressures on the coronary
perfusion pressure, an effect that undoubtedly differs across
the ventricular wall, being greatest in the endocardium. The
postpacing end-diastolic left ventricular and pulmonary ar-
tery occlusive pressures were similar in the two groups, and
thus the difference in calculated coronary resistance during
pacing between patients with and patients without obstruc-
tion is unlikely to be related to omission of the effect of left
ventricular filling pressure on coronary perfusion pressure.
Conclusions. The pathogenetic mechanisms causing
myocardial ischemia differ between patients with obstruc-
tive and nonobstructive hypertrophic cardiomyopathy.
Coronary flow reserve in patients with obstructive hyper-
trophic cardiomyopathy is limited because of high basal and
stress-induced coronary flow requirements related to a high
left ventricular systolic pressure, a situation analogous to
that in valvular aortic stenosis, and in some patients, because
of limited maximal flow capacity. Patients with nonobstruc-
tive hypertrophic cardiomyopathy develop ischemia as a
result of severe impairment of maximal coronary flow ca-
pacity.
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